CDIP1 is a p53-dependent pro-apoptotic effector that regulates cell death through multiple interconnected pathways. It acts as an important mediator of p53-driven apoptosis and TNF-induced cell death, localizing to endosomal and lysosomal compartments where it interacts with proteins including ALG-2, ESCRT-I subunits, and VAP proteins to promote caspase-3/7-mediated apoptosis 1. Beyond apoptosis, CDIP1 functions as a membrane curvature protein involved in endosomal recycling tubule scission; co-depletion of CDIP1 and its paralog LITAF impairs integrin recycling and cell migration 2. CDIP1 also serves as a host receptor for Bacillus cereus hemolysin BL toxin, which activates NLRP3 inflammasome-mediated pyroptosis 3. Clinically, CDIP1 dysregulation appears relevant to multiple disease contexts. In myocardial ischemia/reperfusion injury, CDIP1 expression is cardioprotectively suppressed by natural compounds including naringenin via miR-24-3p 4. In Parkinson's disease models, CDIP1 upregulation drives neuronal apoptosis, oxidative stress, and inflammation through the lncRNA BACE1-AS/miR-214-3p axis 5. In colorectal cancer, the ELK1/miR-31-5p/CDIP1 axis regulates tumor progression 6. Recent evidence suggests autophagy serves as a protective mechanism against CDIP1-induced apoptosis in breast cancer cells 7, potentially affecting drug responses to genotoxic agents.